cbdMD (YCBD)
(Delayed Data from AMEX)
$0.67 USD
0.00 (0.72%)
Updated Jun 3, 2024 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
YCBD 0.67 0.00(0.72%)
Will YCBD be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for YCBD based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for YCBD
Cannabis Stock Gainers And Losers From May 28, 2024
Analyst Maintains ‘Buy’ Rating for cbdMD Amidst Challenges, Citing Brand Strength and Strategic Initiatives
YCBD Stock Earnings: cbdMD Misses EPS, Misses Revenue for Q2 2024
cbdMD Inc (YCBD) Q2 2024 Earnings Call Transcript Highlights: Navigating Challenges with ...
cbdMD's Financial Results: Cost-Cutting Measures For Positive Cash Flow Amid Increasing Losses